Back
United States Lime & Minerals Vs. Kymera Therapeutics Industry Stock Comparison
Buy
65
USLM
United States Lime & Minerals
Last Price:
$136.13
Seasonality Move:
6.7%
Sell
39
KYMR
Kymera Therapeutics
Last Price:
$40.85
Seasonality Move:
2.79%
Buy
65
United States Lime & Minerals (USLM)
is a Buy
Is United States Lime & Minerals a Buy, Sell or Hold?
-
The current United States Lime & Minerals [USLM] share price is $135.09. The Score for USLM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
USLM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Kymera Therapeutics (KYMR)
is a Sell
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $40.79. The Score for KYMR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
KYMR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
USLM Stock Price Chart
What is United States Lime & Minerals's stock price today?
-
The United States Lime & Minerals share price today is $135.09The current trend is moderately bearish and USLM is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $40.79Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
USLM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 43.53 | Sell |
| Chaikin Money Flow: | 35833 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (139.1 - 153.14) | Sell |
| Bollinger Bands (100): | (79.24 - 135.86) | Buy |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.61 | Sell |
| Relative Strength Index (14 RSI): | 40.6 | Sell |
| Chaikin Money Flow: | 196490 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.49 - 46.41) | Sell |
| Bollinger Bands (100): | (42.83 - 48.77) | Sell |
USLM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 139.52 | Sell |
| 20-day SMA: | 146.42 | Sell |
| 50-day SMA: | 131.55 | Buy |
| 200-day SMA: | 87.77 | Buy |
| 8-day EMA: | 138.32 | Sell |
| 20-day EMA: | 141.24 | Sell |
| 50-day EMA: | 131.46 | Buy |
| 200-day EMA: | 94.89 | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.15 | Sell |
| 20-day SMA: | 44.05 | Sell |
| 50-day SMA: | 45.84 | Sell |
| 200-day SMA: | 41.3 | Sell |
| 8-day EMA: | 41.35 | Sell |
| 20-day EMA: | 43.14 | Sell |
| 50-day EMA: | 44.71 | Sell |
| 200-day EMA: | 41.09 | Sell |
United States Lime & Minerals Earnings Growth & USLM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.37 per share.
United States Lime & Minerals Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||